Comparative evaluation of the risk factors in the time of arterial hypertension in combination with hypothyroidism
Z.R. VAKHITOVA, G.A. MUKHETDINOVA, R.M. PHAZLYEVA
Municipal hospital of the city of Gubkinsky, Yamalo-Nenets Autonomous District
Bashkir State Medical University, Ufa
Vakhitova Zulphiya Rashitovna
Physician of therapeutics department
The 1st district, house 21, apt.34, the Yamal-Nenets Autonomous District, the city of Gubkinsky 629830
tel. 8-912-425-26-69, e-mail: zulya-vakhitova@yandex.ru
In order to study the pecularities of arterial hypertension and subclinical hypothyroidism in patients of working age were examined 86 patients with arterial hypertension aged 35 to 50 years. Depending on the functional state of the thyroid gland, patients were divided into 2 groups: the 1st group — 44 patients with arterial hypertension and with normal thyroid function, the 2nd group — 42 patients with arterial hypertension and with subclinical hypothyroidism. All patients underwent a comprehensive examination, was made an identification of target lesions and the definition of asymmetric dimethylarginine (ADMA) in serum. The research results showed that the focus of attention should be the working-age patients with arterial hypertension and hypothyroidism with dyslipidemia. These patients should have timely correction of dyslipidemia and hypothyroidism, as a condition of rational prevention of atherosclerosis.
Key words: arterial hypertension, hypothyroidism, dyslipidemia, asymmetric dimethylarginine (ADMA).
REFERENCES
1. Kardiovaskuljarnaja profilaktika. Nacional’nye rekomendacii // Prilozhenie 2 k zhurnalu «Kardiovaskuljarnaja terapija i profilaktika». — 2011. — № 10 (6).
2. Shal’nova S.A., Deev A.D., Oganov R. G. Faktory, vlijajushhie na smertnost’ ot serdechno-sosudistyh zabolevanij v rossijskoj populjacii // Kardiovask. ter. i profilakt. — 2005. — № 1. — S. 4-9.
3. Boger R.H., Sullivan L.M., Schwedhelm E., Wang T.J., Maas R., Benjamin E.J. et al. Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community // Circulation. — 2009. — № 119. — S. 1592-600.
4. Wang H., Liu J. Plasma asymmetric dimethylarginine and L-arginine levels in Chinese patients with essential hypertension without coronary artery disease // J Cardiovasc Dis Res. — 2011 Jul. — Vol. 2, № 3. — R. 177-80. doi: 10.4103/0975-3583.85265.
5. Balabolkin M.I. Fundamental’naja i klinicheskaja tireoidologija: Rukovodstvo / M.I. Balabolkin, E.M. Klebanova, V.M. Kreminskaja. — M.: Medicina, 2007. — 816 s.
6. Kobalava Zh.D., Kotovskaja Ju.V. Arterial’naja gipertonija: dialogi. Uchebno-metodicheskoe posobie dlja vrachej i pacientov // Optima, Moskva. — 2007. — 40 s.
7. Petunina N.A. Osobennosti techenija zabolevanij shhitovidnoj zhelezy u lic pozhilogo vozrasta / N.A. Petunina // Med. vestn. — 2007. — № 19-20. — S. 13-14.
8. Dzhanashija P.H. Analiz stepeni tjazhesti arterial’noj gipertenzii i sostojanija lipidnogo spektra krovi pri tireotoksikoze i gipotireoze / P.H. Dzhanashija, G.B. Selivanova // II Ros. kardiolog. zhurnal. — 2004. — T. 4, № 48. — S. 27-33.
9. Bakirova N.M. Faktory riska serdechno-sosudistyh oslozhnenij i sostojanie lipidnogo obmena u pozhilyh bol’nyh arterial’noj gipertenziej pri razlichnyh intervalah urovnja tireotropnogo gormona gipofiza / N.M. Bakirova, A.O. Pozdnjak // Prakticheskaja medicina. — Kazan’, 2010. — № 4 (43). — S. 112-117.
10. Samitin V.V. Faktory serdechno-sosudistogo riska, svjazannye s funkciej jendote¬lija, pri subklinicheskom gipotireoze / V.V. Samitin, T.I. Rodionova // Klini¬cheskaja i jeksperimen¬tal’naja tireoidologija. — 2009. — № 1. — S. 26-29.